Changes in Gut Microbiota Composition after Bariatric Surgery: a New Balance to Decode

Area of Science:

• Microbiome research
• Bariatric surgery outcomes
• Obesity and metabolic health

Background:

• The gut microbiota's role in obesity is a growing area of scientific interest.
• Bariatric surgery is a common treatment for obesity, potentially impacting gut microbial composition.
• Understanding these postoperative changes is crucial for developing effective obesity treatments.

Purpose of the Study:

• To investigate the modifications in gut microbial composition following bariatric surgery.
• To compare the effects of Roux-en-Y gastric bypass (RYGB) and laparoscopic sleeve gastrectomy (LSG) on the gut microbiome.
• To identify specific bacterial changes associated with weight loss and improved metabolism.

Main Methods:

• A prospective longitudinal study involving 25 obese patients and 25 lean controls.
• Collection of anthropometric, metabolic, and stool samples before surgery (T0) and at 3 (T3) and 6 (T6) months post-surgery.
• Analysis of gut microbiota composition using stool samples from patients undergoing RYGB and LSG.

Main Results:

• RYGB led to transient increases in specific bacteria (e.g., Yokenella regensburgei, Fusobacterium varium) and a permanent increase in Akkermansia muciniphila, linked to healthy metabolism.
• LSG did not result in significant changes to the gut microbiota.
• RYGB induced greater weight loss and more pronounced microbial alterations compared to LSG.

Conclusions:

• Roux-en-Y gastric bypass significantly reshapes the gut microbiome, promoting beneficial bacteria like Akkermansia muciniphila.
• Laparoscopic sleeve gastrectomy has a limited impact on gut microbial composition.
• Further research into the functional roles of these altered bacteria is essential for developing novel obesity therapeutics.